Seelos Therapeutics, Inc. (SEEL) Financials
SEEL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 5.4 million | 38.9 million |
| 2023-09-30 | 6.2 million | 36.6 million |
| 2023-06-30 | 11.9 million | 59.1 million |
| 2023-03-31 | 23.6 million | 44.3 million |
SEEL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.9 million | 964000 |
| 2023-09-30 | -5.7 million | 974000 |
| 2023-06-30 | -5.9 million | 988000 |
| 2023-03-31 | -10.3 million | 1.1 million |
SEEL Net Income
No data available :(
SEEL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 3.0 million | - | 15000 |
| 2023-09-30 | 2.6 million | - | 31000 |
| 2023-06-30 | 5.8 million | - | 46000 |
| 2023-03-31 | 14.1 million | - | 60000 |
SEEL Shares Outstanding
SEEL Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 5.9 million | 2.7 million | 15000 |
| 2023-09-30 | - | 10.0 million | 3.0 million | - |
| 2023-06-30 | - | 8.5 million | 2.8 million | - |
| 2023-03-31 | - | 5.7 million | 4.1 million | - |
SEEL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 653000 | 15000 |
| 2023-09-30 | 406000 | 14000 |
| 2023-06-30 | 336000 | 14000 |
| 2023-03-31 | 808000 | 14000 |
SEEL
Price: $0.33
52 week price:
Earnings Per Share: -7.73 USD
P/E Ratio: -0.06
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 571600
Market Capitalization: 7.2 million